Should you buy SPTX stock?
Last updated:
Based on market data through , StockInvest.us rates Seaport Therapeutics, Inc. Common Stock (SPTX) as a Buy Candidate with a technical score of 2.86 on its -10 to +10 scale. This is a downgrade from Strong Buy in the previous daily evaluation.
- Buy signal since
- Price since signal Up 12.51%
- 3-month trend forecast Up 36.30%
- Bullish trend confirmed on both short and long timeframes
- Consistently positive technical signals over the last month
- +16.0% YTD performance
Evaluation of Seaport Therapeutics, Inc. Common Stock stock downgraded after the last trading session
(Market data through Aug 10, 2026)
The Seaport Therapeutics, Inc. Common Stock stock price fell by -2.54% on the last day (Monday, 10th Aug 2026) from $23.62 to $23.02. During the last trading day the stock fluctuated 6.14% from a day low at $22.80 to a day high of $24.20. The price has risen in 7 of the last 10 days and is up by 12.07% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -36 thousand shares and in total, 77 thousand shares were bought and sold for approximately $1.76 million.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 36.30% during the next 3 months and, with a 90% probability hold a price between $28.02 and $32.33 at the end of this 3-month period.
SPTX Signals & Forecast
The Seaport Therapeutics, Inc. Common Stock stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $22.09 and $20.76. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, August 07, 2026, and so far it has fallen -2.54%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Seaport Therapeutics, Inc. Common Stock stock
On the downside, the stock finds support just below today's level from accumulated volume at $18.97 and $18.17. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Seaport Therapeutics, Inc. Common Stock finds support just below today's level at $18.97. If this is broken, then the next support from accumulated volume will be at $18.17 and $17.99.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.40 between high and low, or 6.14%. For the last week, the stock has had daily average volatility of 6.07%.
Our recommended stop-loss: $21.94 (-4.71%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 1 day ago.)
Trading Expectations (SPTX) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Seaport Therapeutics, Inc. Common Stock to open at $23.34, and during the day (based on 14 day Average True Range), to move between $22.28 and $23.76, which gives a possible trading interval of +/-$1.48 (+/-6.62%) up or down from last closing price. If Seaport Therapeutics, Inc. Common Stock takes out the full calculated possible swing range there will be an estimated 6.62% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $23.09 (0.30%) than the support at $18.97 (17.59%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Seaport Therapeutics, Inc. Common Stock stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Seaport Therapeutics, Inc. Common Stock stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.
Current score:
2.858
Buy Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $23.34 ( 1.39%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
SPTX Performance
Trading levels for SPTX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 24.74 | 7.47% |
| R2 | 24.21 | 5.15% |
| R1 | 23.87 | 3.71% |
| Price | 23.02 | |
| S1 | 22.81 | -0.93% |
| S2 | 22.47 | -2.37% |
| S3 | 21.94 | -4.69% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 23.62 | 2.61% |
| R1 | 23.09 | 0.304% |
| Price | 23.02 | |
| S1 | 18.97 | -17.59% |
| S2 | 18.17 | -21.07% |
| S3 | 17.99 | -21.85% |
FAQ
Click here for our free guide on how to buy Seaport Therapeutics, Inc. Common Stock Stock.
Buy SPTX